Haleon PLC (GB:HLN) has released an update.
Haleon PLC has announced the purchase of 700,000 of its own shares for cancellation as part of a share buyback program initiated earlier this month, with the move potentially impacting shareholders’ notification requirements under the FCA’s rules. The company, a global leader in consumer health with well-known brands like Advil and Sensodyne, continues to actively manage its share capital. Detailed trade information following this buyback is available on both the London Stock Exchange and Haleon’s website.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
